A National Physician Survey Examining Switching From Sulfonylureas or Insulin to Newer Diabetes Medications
Year: 2024
Type: article
Study design: Observational Study
Abstract: This study was a national survey of U.S. physicians in general medicine, geriatrics, or endocrinology who were asked what medication change they would make for adults with type 2 diabetes taking sulfonylureas or insulin with an A1C below their individualized goal. Responding physicians switched the hypoglycemia-causing medication a median of 4 times (interquartile range 1-9) among 27 opportunities and selected dipeptidyl peptidase 4 inhibitors most often when switching. Sodium-glucose cotransporter 2 inhibitors were selected less frequently, including when indicated for cardiovascular and renal comorbidities, but significantly more often among physicians caring for a greater proportion of patients with private health insurance. Overcoming barriers to switching hypoglycemia-causing medications may help to reduce rates of hypoglycemia while targeting cardiovascular and renal comorbidities.
Source: Clinical Diabetes
DOI: 10.2337/cd24-0043
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: U.S. Deprescribing Research Network, G2099660156, G2362675829, Patient-Centered Care for Older Adults with Multiple Chronic Conditions: Research and Mentoring Program, Improving cancer screening in older adults with limited life expectancy, G5513347805, An intervention to enhance hypoglycemia communication and preventive action in primary care
OpenAlex ID: W4402271463